Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

14,473 total articles

Investors Warn Mercedes’ Luxury-First Strategy May Impede China Recovery

Investors Warn Mercedes’ Luxury-First Strategy May Impede China Recovery

At Mercedes-Benz’s annual shareholders’ meeting, investors cautioned that a strategy concentrated on the upper end of the market could hinder the company’s ability to reclaim Chinese buyers after a sharp sales decline. Executives outlined plans for new models and jointly developed driving assistance systems, while reaffirming medium-term sales targ…

TSX Futures Rise as Hopes Grow for U.S.-Iran Ceasefire Talks

TSX Futures Rise as Hopes Grow for U.S.-Iran Ceasefire Talks

Futures tied to Canada's primary stock index ticked upward Thursday as investors leaned into growing expectations that the U.S. and Iran could negotiate a lasting ceasefire. Benchmark Canadian contracts and U.S. futures gained modestly, while sector performance diverged - financials advanced, energy lagged amid easing oil prices, and gold ticked hi…

Insider Moves: Major Buys at Food and Manufacturing Names, Large Sales at Cloud GPU and Bank Stocks

Insider Moves: Major Buys at Food and Manufacturing Names, Large Sales at Cloud GPU and Bank Stocks

Corporate insiders and significant shareholders reported a string of notable transactions disclosed Wednesday. Purchases included large director buys at Conagra Brands and institutional accumulation at Lamb Weston, along with insider buying at Virco and Airsculpt. On the sell side, executives and large holders completed multi-million-dollar disposa…

UBS Champions European Software Names With Clear Growth Visibility

UBS Champions European Software Names With Clear Growth Visibility

UBS has identified European software companies that combine predictable earnings and exposure to long-term secular trends as preferred investments. The broker highlights The Sage Group Plc and Indra Sistemas as top selections, citing Sage's recurring revenue base and insulation from recent geopolitical disruption and Indra's attractive valuation fo…

BofA: 2026 Marks Shift to Higher Earnings and Lower Valuations

BofA: 2026 Marks Shift to Higher Earnings and Lower Valuations

Bank of America strategists say 2026 has introduced a new market regime characterized by rising corporate earnings alongside falling valuations. The bank highlights more than 10% P/E compression since 2025, projects 13% EPS growth for the year, and retains a year-end S&P 500 target of 7,100. Sector-by-sector, BofA warns that Technology, Media and T…

Abbott Posts Narrow Beat as Exact Sciences Buy Cuts 2026 Outlook

Abbott Posts Narrow Beat as Exact Sciences Buy Cuts 2026 Outlook

Abbott delivered a slight upside to Wall Street's first-quarter profit and revenue forecasts, helped in part by its recently acquired cancer diagnostics business. The company trimmed its 2026 adjusted EPS outlook by $0.20 to reflect the impact of the $23 billion Exact Sciences acquisition, and shares moved lower in premarket trading.

UBS Flags Limited Upside for Select MedTech Names Ahead of Q1 Reports

UBS Flags Limited Upside for Select MedTech Names Ahead of Q1 Reports

UBS analysts say a couple of large European medical-technology companies carry asymmetric downside risk as Q1 reporting approaches, even as the sector as a whole appears to be stabilising after a period of weakness. Straumann and GE Healthcare are singled out for constrained upside or margin pressure, while Alcon, Biomerieux and Fresenius SE are se…

Analysts Lift ASML Targets After Strong Q1 and Upgraded 2026 Guidance

Analysts Lift ASML Targets After Strong Q1 and Upgraded 2026 Guidance

Wall Street analysts raised price targets on ASML after the company reported stronger-than-expected first-quarter results and broadened its fiscal 2026 revenue growth guidance. UBS and Deutsche Bank increased their price objectives to €1,600 from €1,500 and reaffirmed Buy recommendations. ASML also provided shipment targets for low-NA EUV machines …